NICE is developing four pieces of guidance relating to Diabetes over the next two years. Each piece of guidance will focus on a different element of the care pathway, Because of the breadth of advice that will be covered, it will not be possible for one centre to develop all four pieces of guidance. Therefore, the topics have been allocated as follows:
NICE has set up a steering committee to oversee the production of these pieces of guidance. This group, which will include development group members, guideline development group chairs, staff from all three guidance-producing centres and senior NICE staff will identify and act on any gaps or overlaps across the different guidance topics in order to ensure that the final guidance produced is complementary and consistent.
This page provides more detail on the Type 2 Diabetes clinical guideline. Please follow the links above to view details of the other pieces of guidance.
|Scoping workshop:||28 May 2012|
|Consultation on draft scope with stakeholders:||4 July - 29 August 2012|
|Consultation on draft guideline with stakeholders:||7 January 2015 to 4 March 2015|
|Publication date:||August 2015|
|Centre for clinical practice lead:||Christine Carson|
|Communications manager:||Shalu Kanal|
|Guidelines commissioning manager:||
|Guidelines coordinator:||Besma Nash|
|Patient involvement lead:||Emma Chambers|
|Implementation lead:||Kirsty McLean Steel|
|Guidelines Development Group:||The Guideline Development Group (GDG) oversees the development process.|
The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to whom it will apply.